- Perpetually Adaptive Enterprise Press tab for submenu items
Where adaptability meets advantage
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
-
Industries
-
Services
-
Products and Platforms
- Our Brand Press tab for submenu items
With you for the long run
Whether it’s running a marathon or helping businesses thrive in applying new technology innovations at scale, we understand what it takes to keep pushing the limits of what’s possible.
-
About Us
-
Research & Innovation
- Global Studies Press tab for submenu items
Our Thought Leadership Institute
Through studies, reports and points of view, we deliver forward-looking, practical insights on key issues at the intersection of business and tech.
-
Customer Stories
-
Perspectives
- Build a future with us Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Newsroom Press tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
Recent Press releases
View all -
News alerts
Recent News
View all -
Analyst recognition
-
Events
Upcoming events
29 Sep 2025 TCS BaNCS at SIBOS 2025, Frankfurt22 Sep 2025 TCS Life Sciences Forum 2025 LondonView all20 Aug 2025 TCS at AWS Summit Johannesburg 2025 -
Media kit
- Overview Press tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
- Worldwide Press tab for submenu items
Global knowledge. Local support
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
-
Global
-
Localized
Top Results
Showing
10
01 - 07
Next-gen clinical trials via digital platform
Matthew Moyer, Director - Operations and supply tech, Merck, and Narayanan R., Chief Architect - TCS ADD™, discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
14 MINS WATCH
You have these already downloaded
We have sent you a copy of the report to your email again.
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
Engage with our experts at the World Drug Safety Congress Americas 2024 to learn about AI in pharmacovigilance and our TCS ADD™ Safety platform. Join us now.
Events
09 Sep 2024
Join the TCS ADD™ forum at Pace Port™ London to explore AI/generative AI in clinical R&D and pharmacovigilance and how it is transforming life sciences.
Events
22 Sep 2025
Highlights
- Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution.
- Merck and TCS jointly tested a host of features such as electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and bring-your-own-device (BYOD).
- The digitally enabled trials platform (DETP) aims to resolve challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
Enabling patient-centric trials
Clinical trials have been primarily driven by a site-centric approach (such as face-to-face interactions at the site).
The COVID-19 pandemic severely impacted the functioning of traditional clinical trials and opened a world of possibilities to move to the next generation of clinical trials. Augmented by digital technologies, clinical trials improve participant access, engagement enabling patient-centricity.
Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution. The DETP was aimed at resolving challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
The partnership facilitated a host of features being actively tested, viz-a-viz, electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and BYOD.
Related reading
1/4
Solutions
TCS ADD™ Medical Monitoring: Revolutionize Subject Data Analysis
Solution
|
24 Jun 2025
Opens in new tab
2/4
TCS ADD™
Artificial Intelligence – A Game Changer in Unifying Clinical Data
Article
|
20 May 2025
Opens in new tab
3/4
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
video
|
22 Apr 2025
Opens in new tab
4/4
TCS ADD™
Vandita Tripathi
Manas Saha
Automating Third Party Data Transfer Through Digitized Electronic DTA
White Paper
|
18 Dec 2024
Opens in new tab
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our expertsFind out more
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?